103 related articles for article (PubMed ID: 29086015)
1. The role of serum ADAMTS-1 and aggrecan on polycystic ovary syndrome in adolescents and younger-aged females.
Tola EN; Koroglu ND; Yalcin SE; Oral HB
Arch Gynecol Obstet; 2018 Feb; 297(2):487-493. PubMed ID: 29086015
[TBL] [Abstract][Full Text] [Related]
2. Follicular ADAMTS-1 and aggrecan levels in polycystic ovary syndrome.
Tola EN; Karatopuk DU; Koroglu N; Ergin M; Oral HB
J Assist Reprod Genet; 2017 Jun; 34(6):811-816. PubMed ID: 28417352
[TBL] [Abstract][Full Text] [Related]
3. Role of Versican and ADAMTS-1 in Polycystic Ovary Syndrome.
Özler S; Öztaş E; Tokmak A; Ergin M; Kuru Pekcan M; Gümüş Güler B; Yakut Hİ; Yılmaz N
J Clin Res Pediatr Endocrinol; 2017 Mar; 9(1):24-30. PubMed ID: 27908842
[TBL] [Abstract][Full Text] [Related]
4. The predictive effect of inflammatory markers and lipid accumulation product index on clinical symptoms associated with polycystic ovary syndrome in nonobese adolescents and younger aged women.
Tola EN; Yalcin SE; Dugan N
Eur J Obstet Gynecol Reprod Biol; 2017 Jul; 214():168-172. PubMed ID: 28535403
[TBL] [Abstract][Full Text] [Related]
5. Clinical significance of ADAMTS1, ADAMTS5, ADAMTS9 aggrecanases and IL-17A, IL-23, IL-33 cytokines in polycystic ovary syndrome.
Karakose M; Demircan K; Tutal E; Demirci T; Arslan MS; Sahin M; Celik HT; Kazanci F; Karakaya J; Cakal E; Delibasi T
J Endocrinol Invest; 2016 Nov; 39(11):1269-1275. PubMed ID: 27146815
[TBL] [Abstract][Full Text] [Related]
6. Comparison of Serum A Disintegrin and Metalloproteinase with Thrombospondin Motifs-19 Levels in Different Fertility Situations: Could It Be a Serum Marker of Ovarian Function and Oocyte Pool?
Ersoy E; Özler S; Öztaş E; Ersoy AÖ; Ergin M; Tokmak A; Yilmaz N
Gynecol Obstet Invest; 2019; 84(1):6-11. PubMed ID: 29982260
[TBL] [Abstract][Full Text] [Related]
7. Evidence for decreased expression of ADAMTS-1 associated with impaired oocyte quality in PCOS patients.
Xiao S; Li Y; Li T; Chen M; Xu Y; Wen Y; Zhou C
J Clin Endocrinol Metab; 2014 Jun; 99(6):E1015-21. PubMed ID: 24646063
[TBL] [Abstract][Full Text] [Related]
8. A novel biochemical marker -
Yetkin Yildirim G; Tola EN; Dağ I
Gynecol Endocrinol; 2020 Aug; 36(8):673-677. PubMed ID: 31996062
[No Abstract] [Full Text] [Related]
9. Insulin resistance and its relationship with high molecular weight adiponectin in adolescents with polycystic ovary syndrome and a maternal history of polycystic ovary syndrome.
Cankaya S; Demir B; Aksakal SE; Dilbaz B; Demirtas C; Goktolga U
Fertil Steril; 2014 Sep; 102(3):826-30. PubMed ID: 24973036
[TBL] [Abstract][Full Text] [Related]
10. Serum brain natriuretic peptide and C-reactive protein levels in adolescent with polycystic ovary syndrome.
Deveer R; Engin-Üstün Y; Uysal S; Su FA; Sarıaslan S; Gülerman C; Mollamahmutoğlu L
Gynecol Endocrinol; 2012 Aug; 28(8):602-5. PubMed ID: 22316276
[TBL] [Abstract][Full Text] [Related]
11. Polycystic ovarian morphology and the diagnosis of polycystic ovary syndrome: redefining threshold levels for follicle count and serum anti-Müllerian hormone using cluster analysis.
Lie Fong S; Laven JSE; Duhamel A; Dewailly D
Hum Reprod; 2017 Aug; 32(8):1723-1731. PubMed ID: 28854584
[TBL] [Abstract][Full Text] [Related]
12. Association between anti-Mullerian hormone and insulin resistance in non-obese adolescent females with polycystic ovary syndrome.
Tokmak A; Kokanali D; Timur H; Kuntay Kokanali M; Yilmaz N
Gynecol Endocrinol; 2016 Nov; 32(11):926-930. PubMed ID: 27275748
[TBL] [Abstract][Full Text] [Related]
13. Lipid Accumulation Product (LAP) and Visceral Adiposity Index (VAI) as Markers of Insulin Resistance and Metabolic Associated Disturbances in Young Argentine Women with Polycystic Ovary Syndrome.
Abruzzese GA; Cerrrone GE; Gamez JM; Graffigna MN; Belli S; Lioy G; Mormandi E; Otero P; Levalle OA; Motta AB
Horm Metab Res; 2017 Jan; 49(1):23-29. PubMed ID: 27571188
[TBL] [Abstract][Full Text] [Related]
14. Serum irisin levels in patients with polycystic ovary syndrome.
Bostancı MS; Akdemir N; Cinemre B; Cevrioglu AS; Özden S; Ünal O
Eur Rev Med Pharmacol Sci; 2015 Dec; 19(23):4462-8. PubMed ID: 26698239
[TBL] [Abstract][Full Text] [Related]
15. Abnormal expressions of ADAMTS-1, ADAMTS-9 and progesterone receptors are associated with lower oocyte maturation in women with polycystic ovary syndrome.
GohariTaban S; Amiri I; Soleimani Asl S; Saidijam M; Yavangi M; Khanlarzadeh E; Mohammadpour N; Shabab N; Artimani T
Arch Gynecol Obstet; 2019 Jan; 299(1):277-286. PubMed ID: 30446843
[TBL] [Abstract][Full Text] [Related]
16. The Predictive Role of Serum Cystatin C Levels in Polycystic Ovary Syndrome in Adolescents.
Çınar M; Aksoy RT; Güzel Aİ; Tokmak A; Çandar T; Taşçı Y
J Pediatr Adolesc Gynecol; 2016 Aug; 29(4):353-6. PubMed ID: 26740281
[TBL] [Abstract][Full Text] [Related]
17. Serum betatrophin levels are increased and associated with insulin resistance in patients with polycystic ovary syndrome.
Qu Q; Zhao D; Zhang F; Bao H; Yang Q
J Int Med Res; 2017 Feb; 45(1):193-202. PubMed ID: 28222635
[TBL] [Abstract][Full Text] [Related]
18. Elevated serum levels of anti-Müllerian hormone can be introduced as a new diagnostic marker for polycystic ovary syndrome.
Sahmay S; Atakul N; Aydogan B; Aydin Y; Imamoglu M; Seyisoglu H
Acta Obstet Gynecol Scand; 2013 Dec; 92(12):1369-74. PubMed ID: 23980726
[TBL] [Abstract][Full Text] [Related]
19. Relationship between serum anti-Mullerian hormone and clinical parameters in polycystic ovary syndrome.
Matsuzaki T; Munkhzaya M; Iwasa T; Tungalagsuvd A; Yano K; Mayila Y; Yanagihara R; Tokui T; Kato T; Kuwahara A; Matsui S; Irahara M
Endocr J; 2017 May; 64(5):531-541. PubMed ID: 28381699
[TBL] [Abstract][Full Text] [Related]
20. Insulin resistance variability in women with anovulatory and ovulatory polycystic ovary syndrome, and normal controls.
Cho LW; Kilpatrick ES; Keevil BG; Jayagopal V; Coady AM; Rigby AS; Atkin SL
Horm Metab Res; 2011 Feb; 43(2):141-5. PubMed ID: 21234853
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
